Walid Basher

586 total citations
9 papers, 446 citations indexed

About

Walid Basher is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine. According to data from OpenAlex, Walid Basher has authored 9 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 3 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Walid Basher's work include HER2/EGFR in Cancer Research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and BRCA gene mutations in cancer (2 papers). Walid Basher is often cited by papers focused on HER2/EGFR in Cancer Research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and BRCA gene mutations in cancer (2 papers). Walid Basher collaborates with scholars based in Israel and United States. Walid Basher's co-authors include Jamal Zidan, Carlos Cozacov, Amram Hadary, Igor Dashkovsky, Moshe Stein, Edward Rosenblatt, Abraham Kuten, Ora Israel, Zohar Keidar and Osamah Hussein and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

Walid Basher

9 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Walid Basher Israel	7	268	133	118	90	85	9	446
Bernardo Goulart United States	8	294 1.1×	36 0.3×	342 2.9×	43 0.5×	98 1.2×	10	566
Lianghong Teng China	12	99 0.4×	43 0.3×	117 1.0×	46 0.5×	101 1.2×	32	402
Mark Dowar Canada	9	144 0.5×	21 0.2×	104 0.9×	146 1.6×	214 2.5×	12	460
J. Morreau Netherlands	5	194 0.7×	18 0.1×	40 0.3×	59 0.7×	47 0.6×	7	296
C. P. Carden United Kingdom	6	213 0.8×	23 0.2×	37 0.3×	139 1.5×	104 1.2×	8	358
Bisong Haupt United States	11	201 0.8×	18 0.1×	32 0.3×	58 0.6×	69 0.8×	11	386
José Cameselle-Teijeiro Spain	8	103 0.4×	15 0.1×	302 2.6×	44 0.5×	134 1.6×	9	405
Megan Kruse United States	11	248 0.9×	28 0.2×	28 0.2×	144 1.6×	58 0.7×	30	444
André Uchimura Bastos Brazil	12	105 0.4×	23 0.2×	221 1.9×	135 1.5×	236 2.8×	17	494
Irene Forno Italy	12	151 0.6×	20 0.2×	220 1.9×	136 1.5×	277 3.3×	15	541

Countries citing papers authored by Walid Basher

Since Specialization

Citations

This map shows the geographic impact of Walid Basher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walid Basher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walid Basher more than expected).

Fields of papers citing papers by Walid Basher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walid Basher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walid Basher. The network helps show where Walid Basher may publish in the future.

Co-authorship network of co-authors of Walid Basher

This figure shows the co-authorship network connecting the top 25 collaborators of Walid Basher. A scholar is included among the top collaborators of Walid Basher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walid Basher. Walid Basher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Assy, Nimer, et al.. (2012). First-line Treatment With Capecitabine Combined With Irinotecan in Patients With Advanced Colorectal Carcinoma. Journal of Clinical Gastroenterology. 46(4). e27–e30. 7 indexed citations

2.

Zidan, Jamal, et al.. (2011). Differences in pathological and clinical features of breast cancer in Arab as compared to Jewish women in Northern Israel. International Journal of Cancer. 131(4). 924–929. 14 indexed citations

3.

Basher, Walid, et al.. (2010). Differences in clinical and pathological characteristics of colorectal cancer in Arab as compared to Jewish patients in Northern Israel. Familial Cancer. 9(3). 327–330. 3 indexed citations

4.

Zidan, Jamal, et al.. (2005). Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease. British Journal of Cancer. 93(5). 552–556. 230 indexed citations

5.

Zidan, Jamal, et al.. (2004). Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease. Journal of Clinical Oncology. 22(14_suppl). 655–655. 13 indexed citations

6.

Zidan, Jamal, Zohar Keidar, Walid Basher, & Ora Israel. (2004). Effects of Tamoxifen on Bone Mineral Density and Metabolism in Postmenopausal Women with Early-Stage Breast Cancer. Medical Oncology. 21(2). 117–122. 30 indexed citations

7.

Zidan, Jamal, et al.. (2004). Serum CA125: A Tumor Marker for Monitoring Response to Treatment and Follow-up in Patients with Non-Hodgkin's Lymphoma. The Oncologist. 9(4). 417–421. 25 indexed citations

8.

Zidan, Jamal, et al.. (2004). Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease. Journal of Clinical Oncology. 22(14_suppl). 655–655. 3 indexed citations

9.

Zidan, Jamal, et al.. (2003). Pure versus follicular variant of papillary thyroid carcinoma. Cancer. 97(5). 1181–1185. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact